Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
about
Prospects for vaccine prevention of meningococcal infectionPreventative strategies on meningococcal diseaseDesigning vaccines for the twenty-first century societyMurine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.Graphical method for evaluating antibody response to vaccinesMurine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccineSurface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteriaMulticenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type duriTargeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine.Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.
P2860
Q24537338-AE64AEC5-05E5-4CEF-A6BC-76AFE53675CBQ24676339-645953B1-CF7E-431D-91B0-796EC0D7734DQ27025703-F049EA23-E242-4B0E-888D-5FD187BBD644Q33767903-E920C873-96F4-4B61-B4FE-A29301233400Q33903305-875A5537-4EC2-48B0-903B-0297AA9BD0A8Q34003052-A9AC34F0-7B86-418C-87A3-531A802F494CQ34145007-FD0900B4-A3EA-49A3-8BF8-8606CF8DB0D2Q34333219-3174AAE1-6E8F-499A-A012-A748E1AEC013Q34533811-06C7FF54-DA5D-4B9F-9856-098A5AD88835Q35224131-162ACD91-EC6A-42F0-B4D2-94A9145344FEQ35227153-5ED3AF01-E8AC-4183-8C4C-E2FF01AE4040Q36154043-837B11F5-50FD-41D8-8342-A4347ABF9100Q36264198-4E3CC01F-446E-4545-8892-633B5728672DQ36333592-70541252-D007-4AAF-9359-D7C525CA7E43Q36504440-1215491E-9661-427B-A0A4-D53F61FF1AF7Q36689674-A747BAE7-4F7A-467B-8D16-FDB852B0FA87Q37058833-448E9717-DFC4-479F-8021-0DBFAE5BAA9CQ37256135-B9DDA4F2-BC63-494F-A6C3-027225D95D71Q37327673-7A70405F-8E66-4D34-B7F6-FC89CD2704BEQ40184073-3966662D-ACAD-40DF-9492-E6691FCBAC2FQ40598152-8747D036-C534-435E-8DD3-4E185DB00F2CQ41966979-67A3692E-C4E7-415E-8E47-0A444BD69F52
P2860
Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
description
1977 nî lūn-bûn
@nan
1977 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Persistence of antibody follow ...... occal polysaccharide vaccines.
@ast
Persistence of antibody follow ...... occal polysaccharide vaccines.
@en
Persistence of antibody follow ...... occal polysaccharide vaccines.
@nl
type
label
Persistence of antibody follow ...... occal polysaccharide vaccines.
@ast
Persistence of antibody follow ...... occal polysaccharide vaccines.
@en
Persistence of antibody follow ...... occal polysaccharide vaccines.
@nl
prefLabel
Persistence of antibody follow ...... occal polysaccharide vaccines.
@ast
Persistence of antibody follow ...... occal polysaccharide vaccines.
@en
Persistence of antibody follow ...... occal polysaccharide vaccines.
@nl
P2093
P921
P1433
P1476
Persistence of antibody follow ...... occal polysaccharide vaccines.
@en
P2093
Goldschneider I
Gotschlich EC
Randolph M
P304
P407
P577
1977-11-01T00:00:00Z